生物資訊市場規模、佔有率及成長分析（按產品、應用、細分市場和地區）－2025-2032 年產業預測

預計 2023 年全球生物資訊市場規模將達到 116 億美元，並從 2024 年的 131.7 億美元成長到 2032 年的 362.6 億美元，預測期內（2025-2032 年）的複合年成長率為 13.5%。

預計生物資訊市場在預測期內將出現顯著成長，這主要歸因於私人和公共對醫藥研發的投資增加。 RasMol、AUTODOCK 和 Bioclipse 等方便用戶使用的生物資訊學軟體增強了數據可訪問性和分析能力，使其成為研發舉措的必需品。隨著各個「組學」領域的研究項目不斷擴展，對複雜資料儲存和分析解決方案的需求可能會增加。值得注意的是，DNA序列測定技術的進步，例如史丹佛大學醫學院報告的技術，使得在大約八小時內解碼人類基因組成為可能，進一步增加了對基因組分析的需求。這一激增凸顯了生物資訊學在解決與遺傳疾病、化學預防和致癌性研究相關的複雜挑戰中的重要性，並強調了該領域在現代醫學中發揮的關鍵作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 監管分析
• 技術分析
• 案例研究

生物資訊市場規模（依產品/服務）

• 市場概覽
• 知識管理工具
  • 通用知識管理工具
  • 專業的知識管理工具
• 生物資訊平台
  • 數據分析平台
  • 結構與功能分析平台
  • 其他生物資訊平台
• 生物資訊服務
  • 定序服務
  • 數據分析服務
  • 藥物研發服務
  • 差異基因表現分析服務
  • 資料庫和管理服務
  • 其他生物資訊服務

生物資訊市場規模（按應用）

• 市場概覽
• 基因組學
• 化學資訊學與藥物設計
• 蛋白質體學
• 轉錄組學
• 代謝體學
• 其他用途

生物資訊市場規模（按領域）

• 市場概覽
• 醫學生物技術
  • 藥物研發
  • 臨床診斷與個人化醫療
  • 生殖健康
• 動物生物技術
• 植物生物技術
• 環境生物技術
• 法醫學生物技術
• 其他行業

生物資訊市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Illumina Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• Qiagen NV（Netherlands）
• Agilent Technologies Inc.（US）
• BGI Group（China）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Europe）
• Waters Corporation（US）
• DNAnexus Inc.（US）
• Sophia Genetics SA（Switzerland）
• Partek Incorporated（US）
• Gene Codes Corporation（US）
• Dassault Systemes SE（France）
• Biomax Informatics AG（Germany）
• Bruker Corporation（US）
• Macrogen Inc.（South Korea）

結論和建議

Global Bioinformatics Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 13.17 billion in 2024 to USD 36.26 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The bioinformatics market is poised for significant growth during the forecast period, primarily driven by escalating private and public investments in drug research and development. User-friendly bioinformatics software such as RasMol, AUTODOCK, and Bioclipse enhance data accessibility and analysis, making them integral to R&D initiatives. As research programs expand across various '-omics' fields, the demand for sophisticated data storage and analytical solutions is set to increase. Notably, advancements in DNA sequencing technologies, like those reported by Stanford Medicine, can now decode the human genome in about eight hours, further propelling the demand for genomic analysis. This surge emphasizes the importance of bioinformatics in addressing complex challenges related to genetic diseases, chemoprevention, and carcinogen research, underscoring the sector's critical role in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segments Analysis

Global Bioinformatics Market is segmented by Product, Application, Sector and region. Based on Product, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics and Other Applications. Based on Sector, the market is segmented into Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Other Sectors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioinformatics Market

The expansion of personalized medicine is a significant catalyst for the global bioinformatics market. As healthcare shifts toward tailored treatment approaches grounded in individual genetic profiles, there is a rising necessity for bioinformatics tools designed to process and analyze extensive genetic datasets. This escalating demand is propelling the utilization of bioinformatics across pharmaceutical sectors, enhancing diagnostics, evaluation processes, and treatment alternatives. Consequently, the integration of advanced bioinformatics solutions is becoming essential to leverage genetic insights effectively, ultimately fostering more precise and personalized healthcare outcomes. This trend highlights the pivotal role bioinformatics plays in the future of medicine.

Restraints in the Global Bioinformatics Market

The Global Bioinformatics market faces significant challenges due to the high expenses linked to software, hardware, and services. The substantial investment required for bioinformatics systems can pose a financial burden, particularly for smaller research institutions and companies, especially in developing regions with limited market expansion potential. These costs can act as a barrier to entry, inhibiting the adoption of innovative bioinformatics solutions and restricting the overall growth of the market. Consequently, organizations may struggle to access the necessary tools and technologies that facilitate advancements in research and development within the biosciences sector.

Market Trends of the Global Bioinformatics Market

The Global Bioinformatics market is increasingly driven by the integration of artificial intelligence (AI) and machine learning (ML), positioning these technologies as vital components of bioinformatics solutions. These AI-powered tools enhance data analysis capabilities, allowing for expedited and precise interpretation of complex biological datasets. The trend signifies a shift towards improved predictive modeling, more refined pattern recognition, and sophisticated decision-making strategies across various applications, including drug discovery, genomics, and personalized medicine. As the demand for faster and more reliable insights into biological phenomena grows, the bioinformatics sector is poised for robust growth, fostering innovation and collaboration within the life sciences industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Bioinformatics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
• Bioinformatics Platforms
  • Data Analysis Platforms
  • Structural & Functional Analysis Platforms
  • Other Bioinformatics Platforms
• Bioinformatics Services
  • Sequencing Services
  • Data Analysis Services
  • Drug Discovery Services
  • Differential Gene Expression Analysis Services
  • Database And Management Services
  • Other Bioinformatics Services

Global Bioinformatics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Genomics
• Chemoinformatics & Drug Design
• Proteomics
• Transcriptomics
• Metabolomics
• Other Applications

Global Bioinformatics Market Size by Sector & CAGR (2025-2032)

• Market Overview
• Medical Biotechnology
  • Drug Discovery & Development
  • Clinical Diagnostics & Personalized Medicine
  • Reproductive Health
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Other Sectors

Global Bioinformatics Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, Sector)
  • US
  • Canada
• Europe (Product & Service, Application, Sector)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, Sector)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, Sector)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, Sector)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Europe)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAnexus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sophia Genetics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene Codes Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomax Informatics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations